二氢嘧啶脱氢酶基因多态性研究的现状与进展
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2005年第12期1313-1315,共3页
Chinese Journal of Laboratory Medicine
基金
卫生部北京医院重点科研资助项目(200208)
参考文献27
-
1陈新谦 金有豫 汤光.新编药物学(第15版)[M].北京:人民卫生出版社,2004.226.
-
2Heggie GD,Sommadossi JP,Cross DS,et al.Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma,urine,and bile.Cancer Res,1987,47:2203-2206.
-
3Diasio RB,Beavers TL,Carpenter JT.Familial deficiency of dihydropyrimidine dehydrogenase biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.J Clin Invest,1988,81:47-51.
-
4Harris BE,Carpenter JT,Diasio RB.Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency.Cancer,1991,68:499-501.
-
5Lu Z,Zhang R,Diasio RB.Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver:population characteristics,newly identified deficient patients,and clinical implication in 5-fluorouracil chemotherapy.Cancer Res,1993,53:5433-5438.
-
6Fleming RA,Milano G,Thyss A,et al.Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.Cancer Res,1992,52:2899-2902.
-
7Yokota H,Fernandez-Salguero P,Furuya H,et al.cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase,an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria.J Biol Chem,1994,269:23192-23196.
-
8Johnson MR,Wang K,Tillmanns S,et al.Structural organization of the human dihydropyrimidine dehydrogenase gene.Cancer Res,1997,57:1660-1663.
-
9Wei X,McLeod HL,McMurrough J,et al.Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.J Clin Invest,1996,98:610-615.
-
10Wei X,Elizondo G,Sapone A,et al.Characterization of the human dihydropyrimidine dehydrogenase gene.Genomics,1998,51:391-400.
二级参考文献14
-
1Tuchman M,Stoeckeler JS,Kiang DT, et al. Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity[J].N Engl J Med, 1985,313:245-249.
-
2Diasio RB,Beavers TL,Carpenter JT. Familial deficiency of dihydropyrimidine dehydrogenase biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity[J].J Clin Invest, 1988,81:47-51.
-
3Harris BE, Carpenter JT, Diasio RB. Severe 5- fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency[J]. Cancer, 1991,68:499-501.
-
4Wei X, McLeod HL, McMurrough J,et al. Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity[J].J Clin Invest, 1996,98:610-615.
-
5Kouwaki M, Hamajima N, Sumi S,et al. Identification of novel mutations in the dihydropyrimidine dehydrogenase gene in a Japanese patient with 5-fluorouracil toxicity[J].Clin Cancer Res, 1998,4:2999-3004.
-
6Vreken P, Van Kuilenburg ABP, Meinsma R,et al. Identification of novel point mutations in the dihydropyrimidine dehydrogenase gene[J]. J Inher Metab Dis, 1997,20:335-338.
-
7Vreken P,Van Kuilenburg ABP,Meinsma R,et al. Identification of a four-base deletion (del TCAT296-299) in the dihydropyrimidine dehydrogenase gene with variable clinical expression[J].Hum Genet, 1997,100: 263-265.
-
8Wei X, Elizondo G, Sapone A,et al. Characterization of the human dihydropyrimidine dehydrogenase gene[J]. Genomics,1998,51: 391-400.
-
9Ridge SA,Sludden J,Wei X,et al. Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer[J]. Br J Cancer, 1998,77:497-500.
-
10Ridge S A, Sludden J, Brown O,et al. Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects[J].Br J Clin Pharmacol,1998,46:151-156.
共引文献90
-
1赵黎黎,马海战,曹文利,李文杰,张培元,张进平,孙桂芝.利福喷汀治疗耐利福平肺结核80例临床疗效观察[J].中国防痨杂志,2006,28(4):244-246. 被引量:7
-
2孙宝玉.头孢哌酮钠与双硫仑样反应[J].内蒙古民族大学学报,2006,12(4):100-100.
-
3何义富,季楚舒,胡冰.二氢嘧啶脱氢酶及其基因检测与指导化疗的研究进展[J].中国肿瘤,2009,18(12):1003-1007.
-
4褚银平,程金莲,刘爱军,马捷,李新华,邢万红.机械瓣膜替换术后初期抗凝方法的探讨[J].中西医结合心脑血管病杂志,2004,2(8):441-442. 被引量:1
-
5陈华庭,杨嵘,杨颖达.2001~2003年武汉地区医院降糖药物的应用分析[J].医药导报,2004,23(11):818-820. 被引量:1
-
6赵可新,徐列兵.水合氯醛合剂中水合氯醛稳定性考察试验[J].医学理论与实践,2005,18(1):4-5. 被引量:6
-
7白莉.加用中药煎剂治疗急性胰腺炎疗效观察[J].广西中医药,2005,28(1):20-22. 被引量:1
-
8赵占正,肖静,刘章锁.苯溴马隆与别嘌醇治疗高尿酸血症/痛风的疗效观察[J].中国误诊学杂志,2005,5(2):281-282. 被引量:6
-
9李玉芳,陈道英.左氧氟沙星导致精神障碍2例[J].中国煤炭工业医学杂志,2005,8(2):199-199. 被引量:1
-
10史广云.仕泰栓在绝经后妇女取IUD中的应用[J].中国妇幼保健,2005,20(5):637-638. 被引量:7
-
1鲁明骞,徐光川.二氢嘧啶脱氢酶在胃癌中的研究现状[J].世界华人消化杂志,2006,14(34):3290-3293. 被引量:2
-
2李伟平,叶怀庄.高效液相色谱法测定胃癌患者5-氟尿嘧啶血药浓度[J].浙江预防医学,2006,18(6).
-
3祁金友,樊卫,徐克平,汪性展,杨兆东.食管癌患者ATM基因rs664143位点单核苷酸多态性研究[J].临床检验杂志,2012,30(12):987-989. 被引量:2
-
4遗传基因决定患者对肿瘤治疗的反应[J].中国处方药,2004(7):5-5.
-
5刘晓丽,黄勇,杨丽敏,余峰,谷峰,马勇杰.二氢嘧啶脱氢酶基因的T85C和A1627G联合突变对乳腺癌患者预后的影响[J].天津医科大学学报,2016,22(5):412-416.
-
6蔡乐,朱珠.二氢嘧啶脱氢酶基因多态性的研究进展[J].中国药学杂志,2008,43(9):644-648. 被引量:3
-
7张锌,孙步彤,卢振霞.二氢嘧啶脱氢酶基因单核苷酸多态性与结直肠癌患者5-FU化疗毒副作用的关系[J].吉林大学学报(医学版),2011,37(4):707-711. 被引量:11
-
8王素敏,石晓燕,刘晓梅,蒋涛,陈盛强,王庆霞,张伟毅,邵振堂,朱珠.江苏汉族女性蛋氨酸合成酶基因多态性研究[J].中华综合临床医学杂志(北京),2004,6(12):7-8.
-
9王磊,胡冰.二氢嘧啶脱氢酶在结直肠癌中的研究现状及进展[J].安徽医药,2010,14(4):373-375. 被引量:3
-
10石峰,李业山,王建军.多发性骨髓瘤患者血清IL-8水平及其基因启动子多态性研究[J].现代中西医结合杂志,2013,22(30):3323-3324. 被引量:1